{"id":"high-dose-rhcc10","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"rhCC10 works by directly killing or inhibiting the growth of various pathogens, thereby reducing the severity of respiratory infections. Its mechanism of action is not fully understood, but it is thought to involve the disruption of microbial membranes and the inhibition of microbial enzymes.","oneSentence":"High dose rhCC10 is a recombinant human tracheobronchial antimicrobial peptide that has antimicrobial properties.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:58:30.720Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of respiratory infections"}]},"trialDetails":[{"nctId":"NCT01941745","phase":"PHASE2","title":"Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2013-10","conditions":"Respiratory Distress Syndrome in Premature Infant, Bronchopulmonary Dysplasia","enrollment":88},{"nctId":"NCT01473264","phase":"PHASE1, PHASE2","title":"Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)","status":"COMPLETED","sponsor":"Clarassance, Inc.","startDate":"2000-01","conditions":"Respiratory Distress Syndrome in Premature Infant, Bronchopulmonary Dysplasia","enrollment":22}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"High dose rhCC10","genericName":"High dose rhCC10","companyName":"Tufts Medical Center","companyId":"tufts-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"High dose rhCC10 is a recombinant human tracheobronchial antimicrobial peptide that has antimicrobial properties. Used for Treatment of respiratory infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}